Sign in
4/A

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-235039

Director bought 6,100 shares at $4.17 ($25,446)

From the SEC's structured data for this filing

Trades in this filing

Murphy Polly A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-18 Purchase : show line 1 in the form +6,100 $4.17 $25,446 92,145 D
Open-market purchases · 6,100 sh · avg $4.17 · $25,446
Loading xslF345X06/ownership.xml…